We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$605M
AUM Growth
+$125M
Cap. Flow
+$96.3M
Cap. Flow %
15.91%
Top 10 Hldgs %
10.86%
Holding
696
New
282
Increased
102
Reduced
88
Closed
224

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$7.1M
2
INCY icon
Incyte
INCY
+$6.78M
3
TGT icon
Target
TGT
+$5.96M
4
RMD icon
ResMed
RMD
+$5.78M
5
MSCI icon
MSCI
MSCI
+$5.72M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$46.8M
2
WYNN icon
Wynn Resorts
WYNN
+$5.62M
3
AAPL icon
Apple
AAPL
+$5.53M
4
NVS icon
Novartis
NVS
+$5.28M
5
WMT icon
Walmart Inc
WMT
+$4.64M

Sector Composition

Rank Sector Weight
1 Technology 21.66%
2 Consumer Discretionary 17.11%
3 Healthcare 16.08%
4 Industrials 11.44%
5 Financials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISRG icon
376
Intuitive Surgical
ISRG
$127B
$333K 0.06%
974
-1,249
-56% -$378K
GFS icon
377
GlobalFoundries
GFS
$27.4B
$332K 0.05%
+5,146
New +$311K
LPLA icon
378
LPL Financial
LPLA
$28.3B
$331K 0.05%
+1,523
New +$305K
SPXC icon
379
SPX Corp
SPXC
$11B
$330K 0.05%
+3,882
New +$289K
ORLY icon
380
O'Reilly Automotive
ORLY
$72.9B
$326K 0.05%
+5,115
New +$312K
UFPI icon
381
UFP Industries
UFPI
$4.9B
$321K 0.05%
+3,309
New +$276K
MMSI icon
382
Merit Medical Systems
MMSI
$5.08B
$321K 0.05%
+3,833
New +$312K
FTI icon
383
TechnipFMC
FTI
$28.1B
$319K 0.05%
+19,223
New +$271K
DUK icon
384
Duke Energy
DUK
$97.8B
$317K 0.05%
3,528
-8,424
-70% -$795K
FLO icon
385
Flowers Foods
FLO
$1.49B
$316K 0.05%
12,683
-14,548
-53% -$385K
AGI icon
386
Alamos Gold
AGI
$11.6B
$315K 0.05%
+26,419
New +$336K
NEX
387
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$315K 0.05%
+35,196
New +$290K
RL icon
388
Ralph Lauren
RL
$22.6B
$312K 0.05%
+2,529
New +$292K
LNG icon
389
Cheniere Energy
LNG
$55.2B
$307K 0.05%
+2,018
New +$299K
TEL icon
390
TE Connectivity
TEL
$59.6B
$306K 0.05%
+2,186
New +$276K
SNA icon
391
Snap-on
SNA
$21.2B
$305K 0.05%
1,060
-278
-21% -$72K
PII icon
392
Polaris
PII
$3.82B
$304K 0.05%
+2,510
New +$277K
VRSN icon
393
VeriSign
VRSN
$26.2B
$302K 0.05%
1,335
-4,661
-78% -$1.03M
VTYX
394
DELISTED
Ventyx Biosciences
VTYX
$301K 0.05%
+9,184
New +$317K
NVT icon
395
nVent Electric
NVT
$24.9B
$299K 0.05%
+5,783
New +$257K
OC icon
396
Owens Corning
OC
$11.2B
$299K 0.05%
+2,288
New +$251K
GEHC icon
397
GE HealthCare
GEHC
$30.7B
$298K 0.05%
+3,670
New +$293K
ALKS icon
398
Alkermes
ALKS
$8.22B
$297K 0.05%
9,491
-5,665
-37% -$172K
BAP icon
399
Credicorp
BAP
$31.8B
$296K 0.05%
2,008
-456
-19% -$62.6K
WAB icon
400
Wabtec
WAB
$49.1B
$295K 0.05%
+2,694
New +$267K

Similar funds

Seven Eight Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Seven Eight Capital held 696 positions worth $605M, up 26% from $480M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Seven Eight Capital deployed $96.3M of net new capital in Q2 2023, opening 282 new positions and adding to 102 existing holdings. Its largest new stake was AbbVie: 48,404 shares worth $6.52M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Carvana, an estimated $4.53M trimmed.

  • Seven Eight Capital's largest Q2 2023 buy was AbbVie: 48,404 shares worth $6.52M.
  • Seven Eight Capital added most to Las Vegas Sands in Q2 2023, an estimated $4.94M increase.
  • Seven Eight Capital's biggest Q2 2023 reduction was Carvana, cutting an estimated $4.53M.
  • Seven Eight Capital fully exited State Street SPDR S&P 500 ETF Trust in Q2 2023, selling an estimated $46.8M.
  • Seven Eight Capital's ten largest holdings make up 11% of its $605M portfolio in Q2 2023.
  • Seven Eight Capital opened 282 new positions and closed 224 in Q2 2023.
  • Seven Eight Capital's portfolio value rose 26% quarter-over-quarter to $605M.

Based on Seven Eight Capital's 13F filing for Q2 2023, filed 14 Aug 2023.